Home › B-Cell Leukemia › Washington › Spokane
B-Cell Leukemia clinical trials in Spokane, WA
3 studies for B-Cell Leukemia are looking for participants at sites in and around Spokane (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RecruitingPhase 2
- Medical Oncology Associates (Summit Cancer Centers) ( Site 2710), Spokane
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RecruitingPhase 3
- Medical Oncology Associates, PS, Spokane
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
RecruitingPhase 3
- Medical Oncology Associates - Spokane, Spokane
B-Cell Leukemia trials in other cities
- Houston, TX7 studies
- Dallas, TX5 studies
- Washington, DC5 studies
- Columbus, OH4 studies
- Portland, OR4 studies
- Louisville, KY3 studies
- Clifton, NJ3 studies
- New York City, NY3 studies
- Charlotte, NC3 studies
- San Diego, CA3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
Other studies in Spokane
- Non-Small Cell Lung Cancer13 studies
- Colorectal Cancer9 studies
- Breast Cancer8 studies
- Ovarian Cancer8 studies
- Parkinson's Disease7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Cancer (all types)6 studies
- Chronic Lymphocytic Leukemia6 studies
- Prostate Cancer6 studies
- Macular Degeneration5 studies
- Geographic Atrophy5 studies
- Melanoma5 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.